It is also worth noting that JNJ currently has a PEG ratio of 2.83. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Large Cap Pharmaceuticals was hold...
Johnson and Johnson Vision Care is a company focused on eye health, operating in the healthcare sector. The company offers services and products aimed at addressing a range of eye health issues, from childhood myopia to presbyopia and cataracts, providing solutions for vision correction and enhancem...
For a company of JNJ's quality and modest risk profile, we consider a 5% discount to fair value to be a potentially good buying opportunity. And it’s finally trading at a modest but sufficient margin of safety to recommend it. To determine whether or not a company's historical valu...
” Durbin said. “But internal company documents obtained through the discovery process told a different story. They showed that Johnson & Johnson knew about the asbestos in their products while they were actively advertising the use of this product by adults and to use it on our babies.”...
Withits stock down 6.2% over the past three months, it is easy to disregard Johnson & Johnson (NYSE:JNJ). However, the company's fundamentals look pretty decent, and long-term financials are usuall
英国文豪约翰生(S.Johnson) 拒绝去看爱尔兰的名胜「巨人岬」(Giant's Causeway),问他不值得看吗?他答得妙:值得看,但不值得跑去看。Worth seeing?yes ; but not worth going to see.这就是我的「不旅行哲学」。对想象力丰富的人说来,事事要亲临其境,太笨了。我不登月球也能过瘾,你做得到吗? ...
company, but I think that should be factored into the valuation, for example by using a slightly higher discount rate in a discounted cash flow valuation. As an aside, inanother articleI discussed the expected impact of the talc litigation and why I believe it has a negligible impact on...
There’s simply no way around it. A pharmaceutical company worth hundreds of billions of dollars will not willingly admit that their products are harmful. They will not suffer financial loss to make sure their products are safe. And they will not be honest with their employees, customers, or...
In honor of Presidents’ Day, the company’s chief historian shares some stories of special company connections to former U.S. presidents, including the day one leader awardedJohnson & Johnsonwith a medal for a century’s worth of innovation. ...
Hello, everyone. This is Jessica Moore, vice president of investor relations for Johnson & Johnson. Welcome to our company's review of the second quarter business results and our full year financial outlook for 2024. A few logistics before we get into the details. ...